loader
Please Wait
Applying Filters...
menu
    • menu

    Products Under Development 2024 services provided by Bal Pharma

    Virtual BoothMenuBal Pharma
    Products Under Development 2024

    PDF Upload Jul, 2024
    News
    Bal Pharma Net Profit Declines 46.07% In Q3

    14 Feb 2025

    // BUSINESS STD

    Bal Pharma Standalone Net Profit Declines 7.94% In Q3

    14 Feb 2025

    // BUSINESS STD

    Bal Pharma Consolidated June 2024 Net Sales at Rs 74.36 crore, up 5.64% Y-o-Y

    23 Aug 2024

    // MONEYCONTROL

    DATA COMPILATION
    #PharmaFlow

    Bal Pharma

    Contact Supplier

    Website

    BioAsia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Xls

    CATEGORY PAGE
    Menu

    Bal Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI80138